Evalution of Safety, Tolerability and Pharmacokinetics of of HPPH in Ascending Dose for Cancer Patients in Phase I Clinical Trial
Latest Information Update: 05 Nov 2020
At a glance
- Drugs HPPH (Primary)
- Indications Carcinoma; Oesophageal cancer
- Focus Adverse reactions
- Sponsors Zhejiang Hisun Pharmaceutical
- 05 Nov 2020 New trial record